Company: SXTPW
Filing Date: 2025-08-27
Form Type: DEF 14A
Source: 0001213900-25-080878
Chunk: 2

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-08-27
Form: DEF 14A
Chunk 2
---
:00 p.m. (Eastern Time) on October 8, 2025</div>

Notice is hereby given that the 2025 Annual Meeting
of Stockholders (the “Annual Meeting”) of 60 Degrees Pharmaceuticals, Inc., a Delaware corporation (“Company,”
“we,” “us” and “our”), will be held on October 8, 2025 at 12:00 p.m. (Eastern Time) via a live audio
webcast over the telephone. You will be able to virtually attend the Annual Meeting over the telephone and ask questions during the Annual
Meeting. We are holding the Annual Meeting for the following purposes, which are more fully described in the accompanying proxy statement:

| (1) | to elect five (5) directors to serve until the 2026 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified (the “Director Election Proposal”); |

| (2) | to approve an amendment to the 60 Degrees Pharmaceuticals, Inc. 2022 Equity Incentive Plan (the “2022 Plan”) to increase the number of shares of common stock available for issuance by 250,000 shares (the “2022 Plan Amendment Proposal”); |

| (3) | to approve an amendment to our certificate of incorporation, as corrected (“Certificate of Incorporation”), to effect a reverse stock split of our common stock at a reverse stock split ratio ranging from 1:3 to 1:10 inclusive, as determined by our Board of Directors in its sole discretion (the “Certificate of Incorporation Amendment Proposal”); |

| (4) | to ratify the selection by our Board of Directors of RBSM LLP as our independent auditor for the fiscal year ending December 31, 2025 (the “Auditor Proposal”); |

| (5) | to approve adjourning the Annual Meeting, if necessary, to solicit additional proxies in the event there are not sufficient votes in favor of the Director Election Proposal, the 2022 Plan Amendment Proposal and the Certificate of Incorporation Amendment Proposal at the time of the Annual Meeting (the “Adjournment Proposal”); and |

| (6) | to transact such other business as may properly come before the meeting. |

These items of business are more fully described
in the proxy statement (“Proxy Statement”) accompanying this Notice of Annual Meeting of Stockholders (the “Notice”).
We are not aware of any other business to come before the Annual Meeting.

After careful consideration, the Board